1. Big Lessons from Tiny Flies: Drosophila melanogaster as a Model to Explore Dysfunction of Dopaminergic and Serotonergic Neurotransmitter Systems
- Author
-
Ameya Kasture, Sonja Sucic, Thomas Hummel, and Michael Freissmuth
- Subjects
life_sciences_other ,0301 basic medicine ,Neurotransmitter transporter ,neurotransmitter transporters ,vesicular monoamine transporters ,Review ,Cell fate determination ,Serotonergic ,Synaptic Transmission ,Catalysis ,Inorganic Chemistry ,lcsh:Chemistry ,03 medical and health sciences ,Dopamine ,medicine ,Animals ,Physical and Theoretical Chemistry ,Molecular Biology ,Drosophila ,lcsh:QH301-705.5 ,Spectroscopy ,biology ,Dopaminergic Neurons ,Organic Chemistry ,Neurodegeneration ,Dopaminergic ,fungi ,neurodegeneration ,General Medicine ,medicine.disease ,biology.organism_classification ,Computer Science Applications ,serotonin ,Drosophila melanogaster ,030104 developmental biology ,lcsh:Biology (General) ,lcsh:QD1-999 ,dopamine ,Neuroscience ,Serotonergic Neurons ,medicine.drug - Abstract
The brain of Drosophila melanogaster is comprised of some 100,000 neurons, 127 and 80 of which are dopaminergic and serotonergic, respectively. Their activity regulates behavioral functions equivalent to those in mammals, e.g., motor activity, reward and aversion, memory formation, feeding, sexual appetite, etc. Mammalian dopaminergic and serotonergic neurons are known to be heterogeneous. They differ in their projections and in their gene expression profile. A sophisticated genetic tool box is available, which allows for targeting virtually any gene with amazing precision in Drosophila melanogaster. Similarly, Drosophila genes can be replaced by their human orthologs including disease-associated alleles. Finally, genetic manipulation can be restricted to single fly neurons. This has allowed for addressing the role of individual neurons in circuits, which determine attraction and aversion, sleep and arousal, odor preference, etc. Flies harboring mutated human orthologs provide models which can be interrogated to understand the effect of the mutant protein on cell fate and neuronal connectivity. These models are also useful for proof-of-concept studies to examine the corrective action of therapeutic strategies. Finally, experiments in Drosophila can be readily scaled up to an extent, which allows for drug screening with reasonably high throughput.
- Published
- 2018